Predicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125.

Nekulova, Mirka

Predicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125. [electronic resource] - Clinical chemistry Aug 2002 - 1364-7 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0009-9147


Adult
Aged
Antineoplastic Agents, Phytogenic--therapeutic use
CA-125 Antigen--blood
Female
Humans
Middle Aged
Neoplasm Recurrence, Local
Ovarian Neoplasms--diagnosis
Paclitaxel--therapeutic use
Prognosis
Prospective Studies
Reference Values